Prevalence and genotype distribution of high‐risk human papillomavirus infection among women with cervical cytological abnormalities in Chongqing, China, 2014

Prevalence and genotype distribution of high‐risk human papillomavirus infection among women with cervical cytological abnormalities in Chongqing, China, 2014–2020

Published:2021-10-28 Issue:12 Volume:49 Page:1237-1243
ISSN:8755-1039
Container-title:Diagnostic Cytopathology
language:en
Short-container-title:Diagnostic Cytopathology

Author:

Luo Qinli¹^ORCID,Lang Lin¹,Han Na¹,Liang Ling¹,Shen Lianjun¹,Zhang Haiyan¹

Affiliation:

1. Health Examination and Oncology Screening Center Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital Chongqing China

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dc.24891

Reference31 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. The burden of cervical cancer in China: Synthesis of the evidence

3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

4. The epidemiology of human papillomavirus infections

5. Exploring the dynamics and interplay of human papillomavirus and cervical tumorigenesis by integrating biological data into a mathematical model

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesions;Gynecology and Obstetrics Clinical Medicine;2024-04

2. Value of high‑risk human papillomavirus detection combined with colposcopy in the diagnosis of cervical cancer and precancerous lesions;Oncology Letters;2024-02-29

3. Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16–26 years in Chongqing, China;Human Vaccines & Immunotherapeutics;2023-12-15

4. Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China;Human Vaccines & Immunotherapeutics;2023-07-30

5. Comparison of primary cytology, primary HPV testing and co-testing as cervical cancer screening for Chinese women: a population-based screening cohort;BMJ Open;2022-10